2m 2m 2m 2m 2m 2m 2m
Intellia Therape (NTLA)
NASDAQ
$11.15-$0.50 (-4.26%)
Price as of Oct 22, 2026 7:39 PM EDT- $1.6BMarket Cap
- -52.60%1-Year Change
- BiotechnologyIndustry
Intellia Therape (NTLA)
$11.15-$0.50 (-4.26%)
NTLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.65 | ||
Change | -$0.19 (-1.60%) | ||
Open | $11.84 | ||
High | $11.91 | ||
Low | $11.55 | ||
Previous Close | $11.84 | ||
Volume | 2,828,931 | ||
30-Day Average Volume | 5,604,829 | ||
1-Week Change | 1.92% | ||
1-Month Change | -4.66% | ||
1-Year Change | -52.60% | ||
3-Year Change | -56.27% | ||
5-Year Change | -91.32% | ||
Fundamentals | |||
Shares Outstanding | 140.1M | ||
Total Assets | $857.2M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $7.7M | ||
Net Income | -$106.6M | ||
Free Cash Flow | -$84.9M | ||
EBIT | -$106.6M | ||
EBITDA | -$104.6M | ||
Net Working Capital | $448.4M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 199 | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | -12 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue